# Ultan McDermott

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ultan-mcdermott/

## Facts

| Field | Value |
| --- | --- |
| Citations | 62,532 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 82 |
| i10-index | 160 |
| Last Known Institution | AstraZeneca (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5080415325 |
| ORCID iD | https://orcid.org/0000-0001-9032-4700 |
| Works | 520 |

## Researcher papers

- [Signatures of mutational processes in human cancer](https://scholariq.org/papers/signatures-of-mutational-processes-in-human-cancer/)
- [Systematic identification of genomic markers of drug sensitivity in cancer cells](https://scholariq.org/papers/systematic-identification-of-genomic-markers-of-drug-sensitivity-in-cancer-cells/)
- [Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>](https://scholariq.org/papers/clinical-features-and-outcome-of-patients-with-non-small-cell-lung-cancer-who/)
- [MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling](https://scholariq.org/papers/med12-controls-the-response-to-multiple-cancer-drugs-through-regulation-of-tgf/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

## Researcher university

- [AstraZeneca (United Kingdom)](https://scholariq.org/institutions/astrazeneca-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.